Dexcom Inc. - BDR (D1EX34)
Market Closed
12 Jun, 19:55
B3 B3 Primary R$
7. 56
-0.14
-1.8182%
R$
143.16B Market Cap
134.71 P/E Ratio
- Div Yield
511 Volume
1.43 Eps
R$ 7.7
Previous Close Want to track D1EX34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Dexcom Inc. - BDR (D1EX34) Statistics
Valuation metrics
Market Cap 143.16B
Enterprise value 8B
Trailing P/E (ttm) 30.87
Forward P/E -
PEG ratio 0.33
Price/Sales (ttm) 28.43
Price/Book (mrq) 9.25
Enterprise Value/Revenue 0.33
Enterprise Value/EBITDA 1.23
Overview
Shares outstanding 385.9M
Float 384.08M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.72K
Average volume (90 days) 3.65K
Price summary
52-Week low 5.75
52-Week high 10.06
Beta 1.4
50-Day moving average 6.43
200-Day moving average 7.2
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 4:1
Last split Date 13 Jun 2022
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.19%
Operating margin 0.21%
Operational effectiveness
Return on assets 0.1%
Return on equity 0.36%
Income Statement
Revenue (ttm) 24.17B
Revenue per share (ttm) 0.25
Quarterly revenue growth (yoy) 0.15%
Gross profit (ttm) 14.87B
EBITDA 1.48B
Net income to common (ttm) 4.67B
Diluted EPS (ttm) 0.23
Quarterly earnings growth (yoy) 0.89%
Balance Sheet
Total cash (mrq) 12.12B
Total cash per share (mrq) 6.26
Total debt (mrq) 6.95B
Total Debt/Equity (mrq) 46.83
Current ratio (mrq) 1.95%
Book value per share (mrq) 0.77
Cash Flow
Cash flow statement 8.94B
Levered free cash flow (LFCF) 5.3B
